These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14116733)

  • 41. Treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (P32); a preliminary report.
    RUSCHE C; JAFFE HL
    Trans West Sect Am Urol Assoc; 1953; 20():105-14. PubMed ID: 13179272
    [No Abstract]   [Full Text] [Related]  

  • 42. Destruction of the hypophysis with radioactive colloidal chromic phosphate in cancer of the prostate.
    JOHNSON PC; WEST KM; RUTLEDGE BJ
    J Neurosurg; 1958 Sep; 15(5):519-27. PubMed ID: 13576195
    [No Abstract]   [Full Text] [Related]  

  • 43. Distribution of colloidal radioactive chromic phosphate after intracavitary administration.
    ROOT SW; TYOR MP; ANDREWS GA; KNISELEY RM
    Radiology; 1954 Aug; 63(2):251-9. PubMed ID: 13194879
    [No Abstract]   [Full Text] [Related]  

  • 44. [A new method of preparation of colloidal chromium radiophosphate. Study of the mechanism of formation and biological behavior].
    BELLION B; BUCHI G; CHIARLE S; GOVERNA M; ORSELLO S; ROSA U; SCASSELLATI GA
    Minerva Nucl; 1962; 6():201-8. PubMed ID: 13967146
    [No Abstract]   [Full Text] [Related]  

  • 45. Radioactive colloidal chromic phosphate in the treatment of ovarian malignancies.
    Hester HL; White L
    Am J Obstet Gynecol; 1969 Apr; 103(7):911-8. PubMed ID: 4180205
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of radioactive colloidal chromic phosphate for the treatment of malignant effusion.
    CARLILE T; MOORES KD; HARRIS V
    Bull Mason Clin; 1959 Sep; 13():67-73. PubMed ID: 13807738
    [No Abstract]   [Full Text] [Related]  

  • 47. In vivo soubilization of insoluble chromium compounds: hydrolysis of 51Cr-cromic-32P-phosphate.
    Anghileri LJ
    Nucl Med (Stuttg); 1968 Aug; 7(2):184-94. PubMed ID: 4972152
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (p32); a preliminary report.
    RUSCHE C; JAFFE HL
    J Urol; 1954 Sep; 72(3):466-75. PubMed ID: 13202235
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of malignant serous effusions with radioactive colloidal chromic phosphate.
    JAFFE HL
    Am J Roentgenol Radium Ther Nucl Med; 1955 Oct; 74(4):657-66. PubMed ID: 13258923
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study on the distribution of radioactive colloidal chromic phosphate after intracardiac and intraperitoneal injection in rats].
    PERRONI GL; FERRINI O; BESTAGNO M; BIASSONI P
    Arch Maragliano Patol Clin; 1958 Dec; 14(6):1797-804. PubMed ID: 13650836
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative study of the distribution of intrapleurally injected colloidal radioactive chromic phosphate (CrP32O4) and gold (Au198) in the guinea pig.
    SCHEININ TM; LAUSTELA E
    Ann Chir Gynaecol Fenn; 1958; 47(4):420-7. PubMed ID: 13617686
    [No Abstract]   [Full Text] [Related]  

  • 52. Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.
    Kim JY; Bom HS; Kim YJ; Choi W
    Radiat Med; 1990; 8(6):246-9. PubMed ID: 2093946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of radioactive colloid binding by tumor cells.
    Anghileri LJ; Marchal C; Maincent P; Robert J
    Tumori; 1990 Jun; 76(3):217-9. PubMed ID: 2368163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of colloid uptake by tumor cell surface electrical charge modification.
    Anghileri LJ; Maincent P; Robert J
    Biochim Biophys Acta; 1989 Jul; 982(2):307-8. PubMed ID: 2752031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [PROBLEMS OF THE DOSE, TOTAL AND REGIONAL, IN THE USE OF TRACERS WITH LIVER FIXATION].
    BECCHINI MF
    Minerva Nucl; 1964; 8():231-4. PubMed ID: 14177182
    [No Abstract]   [Full Text] [Related]  

  • 56. Palliative treatment of prostatic cancer with radioactive colloidal chromic phosphate: three years experience and results.
    RUSCHE C; JAFFE HL
    J Urol; 1955 Sep; 74(3):393-401. PubMed ID: 13252720
    [No Abstract]   [Full Text] [Related]  

  • 57. Synoviorthesis with colloidal 32P chromic phosphate for hemophilic arthropathy: clinical follow-up.
    Rivard GE; Girard M; Lamarre C; Jutras M; Danais S; Guay JP; Bélanger RD
    Arch Phys Med Rehabil; 1985 Nov; 66(11):753-6. PubMed ID: 4062528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical use of radioactive chromium phosphate].
    YAMASHITA H; SUZUKI M
    Gan; 1953 Sep; 44(2-3):334. PubMed ID: 13128182
    [No Abstract]   [Full Text] [Related]  

  • 59. Distribution and effect of colloidal chromic phosphate (P32) injected into the hepatic artery and portal vein of dogs and man.
    LEVINE B; HOFFMAN H; FREEDLANDER SO
    Cancer; 1957; 10(1):164-72. PubMed ID: 13413814
    [No Abstract]   [Full Text] [Related]  

  • 60. Unit dose dispensing of chromic phosphate P 32 suspension.
    Hung JC
    Am J Hosp Pharm; 1994 Dec; 51(24):3081. PubMed ID: 7856633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.